| 51 |
12973835 | ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpression. | 2003 Sep 15 |
1 |
| 52 |
11748447 | The role of HER-2 oncoprotein in drug-sensitivity in breast cancer (review). | 2002 Jan-Feb |
3 |
| 53 |
11872346 | C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer. | 2002 Mar |
1 |
| 54 |
11208823 | Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables. | 2001 Jan 15 |
2 |
| 55 |
11694791 | The predictive value of HER2 in breast cancer. | 2001 |
1 |
| 56 |
11759828 | HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer. | 2001 Sep |
2 |
| 57 |
10623878 | Role of HER2 gene overexpression in breast carcinoma. | 2000 Feb |
1 |
| 58 |
11121461 | HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15. | 2000 Dec 20 |
1 |
| 59 |
11236028 | The role of HER-2 expression in predicting response to therapy in breast cancer. | 2000 Dec |
1 |
| 60 |
12849612 | Prognostic and predictive implications of HER2 status for breast cancer patients. | 2000 Mar |
1 |
| 61 |
10327070 | Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers. | 1999 Apr 1 |
1 |
| 62 |
10561274 | Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expression. | 1999 Jul |
2 |
| 63 |
9667258 | Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy. | 1998 Jul |
1 |
| 64 |
9110342 | HER2 overexpression and paclitaxel sensitivity in breast cancer: therapeutic implications. | 1997 Mar |
1 |
| 65 |
7896881 | p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. | 1995 Mar |
2 |
| 66 |
7584078 | Gene therapy for cancer using tumour-specific prodrug activation. | 1994 May |
2 |
| 67 |
7908410 | c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. | 1994 May 5 |
3 |
| 68 |
1351538 | Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. | 1992 Jul |
1 |
| 69 |
1355336 | Overexpression of erbB-2 protein in gastric adenocarcinoma--a potential role in therapeutic response to adjuvant 5-FU-doxorubicin regimen. | 1992 Jul |
2 |